Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Europe Radiotherapy Market Size, Share, Growth, Trends, and Industry Analysis: By Equipment, By Type, By Application, By End User and Country Forecast 2020-2031
Europe Radiotherapy Market size was valued at US$ 7,940.9 million in 2024 and is expected to reach US$ 10,309.8 million by 2031, growing at a significant CAGR of 3.8% from 2025-2031. Radiotherapy is a painless treatment which is extensively used in cancer treatment. It works on the principle of damaging cancerous cells by destruction of DNA inside cells by radiation. It slows down the cancerous cell's growth and provides comfort by relieving the patients with cancer symptoms. Cancer is the abnormal growth and spread of cells which arises from a change in a single cell. Change may be due to external agents and inherited genetic factors and can affect almost any body part. Cancer can be prevented by avoiding exposure to the common risk factors, by surgery, radiotherapy and chemotherapy. Europe has wide variances in accessing radiation therapy services, scantiness in infrastructure and skilled professionals.
As per, the International Atomic Energy Agency (IAEA) report 2012, about 1286 radiotherapy centres registered in the DIRAC database in Europe. Germany has the largest number with 289 centres, France with 177, Italy with 172 centres and Spain has 117 centres respectively. Netherlands and UK along with Nordic countries (Scandinavia, Finland and Iceland) have the most centralized radiotherapy infrastructure with more treatment equipment and fewer facilities at each centre. In February 2017, Elekta and the European Society for Radiotherapy and Oncology (ESTRO) Cancer Foundation (ESF) to contribute to the mission of every patient in Europe will have access to state of the art of radiation. In June 2011, Cayman chemical company has adopted the Genedata screener of Genedata, the company of advanced software solutions for drug discovery and life science research as a data management platform for Cayman's new epigenetic screening laboratory.
Radiotherapy market in Europe is driven by various factors like growing number of cancer patients, favourable non-government and government funds in R&D of cancer treatment. Furthermore, inclination towards non-invasive techniques and decreased cost of treatment in the developed areas are expected to boost the growth of the radiotherapy market in Europe. However, side effects like skin problems, fertility issues, loss of hair and appetite and also harms caused to other healthy cells because of high dosage of radiation will restrain the growth of radiotherapy market in Europe. Moreover, costs associated with training the professionals, difficulty in maintenance and up gradation of equipment are expected to hamper the Europe radiotherapy market.
Report Benchmarks |
Details |
Market Size in 2024 |
US$ 7,940.9 million |
Market Size in 2031 |
US$ 10,309.8 million |
By Equipment |
|
By Type |
|
By Application |
|
By End User |
|
By Country |
|
Download Free Sample Report
Europe radiotherapy market size was valued at US$ 7,940.9 million in 2024 and is expected to reach US$ 10,309.8 million by 2031, growing at a significant CAGR of 3.8% from 2025-2031
Beam Applications SA RaySearch Laboratories AB Elekta AB Nordion Inc. C. R. Bard Inc. Varian Medical Systems Inc. Mevion Medical Systems Inc.
The Europe Radiotherapy Market segments are by equipment, by type, application and end user
Key Market Players